Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$36.71 - $109.66 $26.7 Million - $79.9 Million
-728,183 Reduced 81.33%
167,213 $6.48 Million
Q2 2022

Aug 11, 2022

SELL
$35.24 - $47.1 $17.2 Million - $23 Million
-489,233 Reduced 35.33%
895,396 $33.4 Million
Q1 2022

May 16, 2022

BUY
$40.9 - $45.1 $11.7 Million - $12.9 Million
285,945 Added 26.03%
1,384,629 $61.3 Million
Q4 2021

Feb 14, 2022

SELL
$38.07 - $44.87 $36.7 Million - $43.3 Million
-964,613 Reduced 46.75%
1,098,684 $46.7 Million
Q3 2021

Nov 15, 2021

SELL
$41.23 - $45.88 $10.7 Million - $11.9 Million
-259,719 Reduced 11.18%
2,063,297 $89.5 Million
Q2 2021

Aug 16, 2021

SELL
$38.58 - $44.24 $33.8 Million - $38.7 Million
-874,950 Reduced 27.36%
2,323,016 $99.3 Million
Q1 2021

May 17, 2021

BUY
$35.27 - $39.67 $17.5 Million - $19.6 Million
495,085 Added 18.32%
3,197,966 $124 Million
Q4 2020

Feb 16, 2021

BUY
$33.15 - $41.97 $55 Million - $69.6 Million
1,657,829 Added 158.64%
2,702,881 $97.2 Million
Q3 2020

Nov 16, 2020

SELL
$34.44 - $42.23 $36.8 Million - $45.1 Million
-1,067,949 Reduced 50.54%
1,045,052 $39.9 Million
Q2 2020

Aug 14, 2020

SELL
$30.19 - $39.11 $8.3 Million - $10.7 Million
-274,858 Reduced 11.51%
2,113,001 $74.2 Million
Q1 2020

May 15, 2020

BUY
$25.83 - $45.71 $61.7 Million - $109 Million
2,387,859 New
2,387,859 $77.9 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Glenview Capital Management, LLC Portfolio

Follow Glenview Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenview Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glenview Capital Management, LLC with notifications on news.